论文部分内容阅读
糖尿病肾病是糖尿病中、晚期患者的并发症之一,重者可危及生命,因此探讨糖尿病肾病的治疗是我们临床医务工作者的一个紧迫的课题。蛋白尿是糖尿病肾病的临床表现之一,既往常规药物治疗对蛋白尿的改善无明显疗效。为此,我们在采用常规治疗的基础上加用卡托普利,发现其对糖尿病肾病蛋白尿的治疗取得一定疗效,故血管紧张素转换酶抑制剂是目前应用于治疗糖尿病肾病的最广泛、疗效最确切的一类药物。
Diabetic nephropathy is one of the complications in patients with advanced and mid-stage diabetes mellitus. In severe cases, it can be life-threatening. Therefore, exploring the treatment of diabetic nephropathy is an urgent issue for our clinicians. Proteinuria is one of the clinical manifestations of diabetic nephropathy, past conventional drug therapy for the improvement of proteinuria no significant effect. To this end, we use conventional treatment based on the use of captopril and found that the treatment of diabetic nephropathy proteinuria achieved some effect, so angiotensin converting enzyme inhibitors are currently used in the treatment of diabetic nephropathy the most extensive, The exact effect of a class of drugs.